Aspire Biopharma Holdings, Inc. (ASBP)

Aspire Biopharma Holdings Statistics

Total Valuation

ASBP has a market cap or net worth of $4.86 million. The enterprise value is $11.81 million.

Market Cap	4.86M
Enterprise Value	11.81M

Important Dates

The next estimated earnings date is Tuesday, February 24, 2026, before market open.

Earnings Date	Feb 24, 2026
Ex-Dividend Date	n/a

Share Statistics

ASBP has 2.69 million shares outstanding. The number of shares has decreased by -99.72% in one year.

Current Share Class	2.69M
Shares Outstanding	2.69M
Shares Change (YoY)	-99.72%
Shares Change (QoQ)	+0.39%
Owned by Insiders (%)	12.03%
Owned by Institutions (%)	2.81%
Float	2.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2,644.02
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6,083.72
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.17

Current Ratio	0.17
Quick Ratio	0.14
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.69

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-195.11%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	35.25%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.61% in the last 52 weeks. The beta is 0.82, so ASBP's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	-99.61%
50-Day Moving Average	3.91
200-Day Moving Average	12.71
Relative Strength Index (RSI)	30.68
Average Volume (20 Days)	1,406,198

Short Selling Information

Short Interest	11.15M
Short Previous Month	13.53M
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.62

Income Statement

In the last 12 months, ASBP had revenue of $1,941 and -$20.54 million in losses. Loss per share was -$16.59.

Revenue	1,941
Gross Profit	884
Operating Income	-4.04M
Pretax Income	-20.54M
Net Income	-20.54M
EBITDA	n/a
EBIT	-4.04M
Loss Per Share	-$16.59

Balance Sheet

The company has $1.95 million in cash and $8.62 million in debt, with a net cash position of -$6.68 million or -$2.48 per share.

Cash & Cash Equivalents	1.95M
Total Debt	8.62M
Net Cash	-6.68M
Net Cash Per Share	-$2.48
Equity (Book Value)	-11.47M
Book Value Per Share	-9.26
Working Capital	-11.46M

Cash Flow

Operating Cash Flow	-3.52M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	45.54%
Operating Margin	-208,054.56%
Pretax Margin	-1,058,156.83%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	99.72%
Shareholder Yield	99.72%
Earnings Yield	-400.21%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 16, 2026. It was a reverse split with a ratio of 1:40.

Last Split Date	Jan 16, 2026
Split Type	Reverse
Split Ratio	1:40

Scores

ASBP has an Altman Z-Score of 151.82 and a Piotroski F-Score of 1.

Altman Z-Score	151.82
Piotroski F-Score	1